Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares were up 36.8% on Friday . The company traded as high as C$0.13 and last traded at C$0.13. Approximately 929,313 shares changed hands during trading, an increase of 383% from the average daily volume of 192,453 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The company has a market capitalization of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32. The firm’s 50-day simple moving average is C$0.08 and its 200-day simple moving average is C$0.06. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Recommended Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Stock Analyst Ratings and Canadian Analyst Ratings
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- Business Services Stocks Investing
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
